BioArctic prices SSE IPO

On Oct. 12, neurodegenerative disease company BioArctic AB (SSE:BIOA B) raised SEK700 million ($83.6 million) through the sale of 29.2 million shares at SEK24 in an IPO on NASDAQ Stockholm underwritte...